Doxapram HCl CAS 7081-53-0

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

7081-53-0

Name

Doxapram HCl

Syn­onyms

1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochlo­ride hydrate 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone mono­hy­drochlo­ride mono­hy­drate 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrochlo­ride hydrate [ACD/IUPAC Name] 1-Éthyl-4-[2-(4-morpholinyl)éthyl]-3,3-diphényl-2-pyrrolidinone, chlorhy­drate, hydrate [French] [ACD/IUPAC Name] 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinonhydrochloridhydrat [Ger­man] [ACD/IUPAC Name] 1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochlo­ride hydrate 204-022-3 [EINECS] 2-Pyrro­­lidi­none, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochlo­ride, hydrate (1:1:1) [ACD/​Index Name] 7081-53-0 [RN] Dopram [Trade name] [Wiki] Doxapram Hydrochlo­ride Doxapram Hydrochlo­ride hydrate Doxapram mono­hy­drochlo­ride mono­hy­drate P5RU6UOQ5Y Stim­ulex­in UNII :P5RU6UOQ5Y (±)-doxapram hydrochlo­ride mono­hy­drate [7081-53-0] 113-07-5 [RN] 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one and hydron and chlo­ride and hydrate 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydron;chloride;hydrate 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, mono­hy­drochlo­ride, mono­hy­drate(8CI) 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochlo­ride 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one mono­hy­drochlo­ride 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochlo­ride 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochlo­ride, hydrate(1:1:1) 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, mono­hy­drochlo­ride, mono­hy­drate (9CI) 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrate hydrochlo­ride 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochlo­ride mono­hy­drate 1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochlo­ride – water (1/1) 2-Pyrro­­lidi­none, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, mono­hy­drochlo­ride, mono­hy­drate 2-Pyrro­­lidi­none, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, mono­hy­drochlo­ride, mono­hy­drate 2-Pyrro­­lidi­none, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, mono­hy­drochlo­ride, mono­hy­drate 4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chlo­ride – water (1/1) Dopram hydrochlo­ride hydrate Dopram hydrochlo­ride hydrate;Stimulex hydrochlo­ride hydrate;Respiram hydrochlo­ride hydrate Doxapram (hydrochlo­ride hydrate) DOXAPRAM HCL Doxapram hydrochlo­ride mono­hy­drate Doxapram Hydrochlo­ride Mono­hy­drate 1.0 mg/​ml in Methanol (as anhy­drous free base) hydrate Hydrochlo­ride HYDRO­GEN DOXAPRAM HYDRATE CHLO­RIDE MFCD09954698 Res­pi­ram hydrochlo­ride hydrate Stim­ulex hydrochlo­ride hydrate

SMILES

CCN1CC(C(C1=O)(c2ccccc2)c3ccccc3)CCN4CCOCC4.O.Cl

Std­InChI

InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3 ;1H ;1H2

Std­InChIKey

ZOMBFZR­WM­LID­PX-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C24H30N2O2.HCl.H2O

Mol­e­c­u­lar Weight

432.99

Prop­er­ties

Appear­ance

White to off-white crys­talline pow­der

Melt­ing Point

Around 220℃

Safe­ty Data

Sym­bol

GHS06

Sig­nal Word

Dan­ger

Haz­ard Statements

H301

Pre­cau­tion­ary Statements

Miss­ing Phrase – N15.00950417

RIDADR

UN 2811 6.1 / PGI­II

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Doxapram HCl CAS 7081-53-0

Stan­dard

USP38

Iden­ti­fi­ca­tion Methods

IR,UV

Assay

98.0%~100.5%

Heavy Met­als

≤20ppm

pH

3.5~5.0

Loss on Drying

3.0%~4.5%

Residue on Ignition

≤0.3%

Organ­ic Impurities

≤0.2%

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

It is com­mon­ly used for res­pi­ra­to­ry depres­sion caused by cen­tral inhibito­ry drugs, acute res­pi­ra­to­ry fail­ure, COPD com­pli­cat­ed with acute res­pi­ra­to­ry fail­ure, and accel­er­at­ed wake-up after anes­the­sia.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​d​o​x​a​p​r​a​m​-​h​c​l​-​c​a​s​-​7​0​8​1​-​5​3​-0/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).